尿石素在精神疾病中的神经调节作用及应用前景

doi:10.3969/j.issn.1006-5725.2023.18.021

Abstract

Abstract:

Mental disorders are a group of complex neurological conditions with unclear etiologies， characterized by abnormalities in cognitive， emotional， volitional， and behavioral functions. The prevalence of mental disorders is increasing， whereas the development of effective drugs has been slow， greatly impacting the mental and physical well-being and quality of life in patients. Consequently， the development and application of new drugs have become a hot topic in current research. In recent years， urolithins， as natural bioactive compounds， have garnered widespread attention among researchers. By crossing the blood-brain barrier， urolithins play neuroprotective roles including anti-inflammatory， antioxidant， and anti-apoptotic effects. They are considered potential small molecules for modulating the nervous system， with potential clinical applications for symptom improvement and rehabilitation in mental disorders. However， no research on the application of urolithins for mental disorders has been currently reported. In this review， we summarize the recent domestic and international research on the neuroregulatory mechanisms and therapeutic potential of urolithins for mental disorders， aiming to provide new directions for research in mental disorders and offer novel insights for the development and clinical conversion of urolithin-based treatments for mental disorders.

Key words: urolitrin, schizophrenia, depressive disorder, neuroregulation

CLC Number:

R964

Zhengyuan HUANG,Lirong ZHAO,Kexuan ZHANG,Gaohua WANG,Benhong. ZHOU. The neuroregulatory effects and potential applications of urolithins in mental disorders[J]. The Journal of Practical Medicine, 2023, 39(18): 2405-2410.

Figures/Tables 1

References 49

1	ONITSUKA T， HIRANO Y， NEMOTO K， et al. Trends in big data analyses by multicenter collaborative translational research in psychiatry［J］. Psychiatry Clin Neurosci， 2022， 76（1）： 1-14.
2	SUN Y， JI M， ZHANG X， et al. Comparative effectiveness and acceptability of different ACT delivery formats to treat depression： A systematic review and network meta-analysis of randomized controlled trials［J］. J Affect Disord， 2022， 9（313）： 196-203.
3	GARCIA-VILLALBA R， GIMENEZ-BASTIDA J A， CORTES-MARTIN A， et al. Urolithins： a Comprehensive Update on their Metabolism， Bioactivity， and Associated Gut Microbiota［J］. Mol Nutr Food Res， 2022， 66（21）： e2101019.
4	KUJAWSKA M， JOURDES M， KURPIK M， et al. Neuroprotective Effects of Pomegranate Juice against Parkinson's Disease and Presence of Ellagitannins-Derived Metabolite-Urolithin A-In the Brain［J］. Int J Mol Sci， 2019， 21（1）：202.
5	LIU J， JIANG J， QIU J， et al. Urolithin A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1alpha signaling pathway［J］. Food Funct， 2022， 13（1）： 375-385.
6	NUNEZ-SANCHEZ M A， GARCIA-VILLALBA R， MONED-ERO-SAIZ T， et al. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma， urine and colon tissues from colorectal cancer patients［J］. Mol Nutr Food Res， 2014， 58（6）： 1199-1211.
7	LU C， LI X， GAO Z， et al. Urolithins and intestinal health［J］. Drug Discov Ther， 2022， 16（3）： 105-111.
8	D'AMICO D， ANDREUX P A， VALDES P， et al. Impact of the Natural Compound Urolithin A on Health， Disease， and Aging［J］. Trends Mol Med， 2021， 27（7）： 687-699.
9	CHEN P， GUO Z， CHEN F， et al. Recent Advances and Perspectives on the Health Benefits of Urolithin B， A Bioactive Natural Product Derived From Ellagitannins［J］. Front Pharmacol， 2022， 6（13）： 917266.
10	XU J， YUAN C， WANG G， et al. Urolithins Attenuate LPS-Induced Neuroinflammation in BV2Microglia via MAPK， Akt， and NF-kappaB Signaling Pathways［J］. J Agric Food Chem， 2018， 66（3）： 571-580.
11	SHIN N R， WHON T W， BAE J W. Proteobacteria： microbial signature of dysbiosis in gut microbiota［J］. Trends Biotechnol， 2015， 33（9）： 496-503.
12	CERETTA L B， REUS G Z， ABELAIRA H M， et al. Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients［J］. Acta Diabetol， 2012， 49 ： S227-S234.
13	KWON H S， KOH S H. Neuroinflammation in neurodegenerative disorders： the roles of microglia and astrocytes［J］. Transl Neurodegener， 2020， 9（1）： 42.
14	陆彩莲，黄正元，陈弘旭，等. 长链非编码RNA在精神分裂症中的研究进展［J］. 实用医学杂志，2021，37（19）：2559-2562.
15	HERING N A， LUETTIG J， JEBAUTZKE B， et al. The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro ［J］. Front Pharmacol， 2021， 3（12）： 610164.
16	FANG E F， HOU Y， PALIKARAS K， et al. Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease ［J］. Nat Neurosci， 2019， 22（3）： 401-412.
17	SALIM S. Oxidative Stress and the Central Nervous System ［J］. J Pharmacol Exp Ther， 2017， 360（1）： 201-205.
18	CASEDAS G， LES F， CHOYA-FOCES C， et al. The Metabolite Urolithin-A Ameliorates Oxidative Stress in Neuro-2a Cells， Becoming a Potential Neuroprotective Agent ［J］. Antioxidants （Basel）， 2020， 9（2）：177.
19	TALAROWSKA M， SZEMRAJ J， BERK M， et al. Oxidant/antioxidant imbalance is an inherent feature of depression ［J］. BMC Psychiatry， 2015， 4（15）： 71.
20	BOOKHEIMER S Y， RENNER B A， EKSTROM A， et al. Pomegranate juice augments memory and FMRI activity in middle-aged and older adults with mild memory complaints ［J］. Evid Based Complement Alternat Med， 2013， 7（2013）： 946298.
21	HUANG W C， LIOU C J， SHEN S C， et al. Urolithin A Inactivation of TLR3/TRIF Signaling to Block the NF-kappaB/STAT1 Axis Reduces Inflammation and Enhances Antioxidant Defense in Poly（I：C）-Induced RAW264.7 Cells ［J］. Int J Mol Sci， 2022， 23（9）：4697.
22	FRAGUAS D， DIAZ-CANEJA C M， AYORA M， et al. Oxidative Stress and Inflammation in First-Episode Psychosis： A Systematic Review and Meta-analysis ［J］. Schizophr Bull， 2019， 45（4）： 742-51.
23	LEE G， PARK J S， LEE E J， et al. Anti-inflammatory and antioxidant mechanisms of urolithin B in activated microglia ［J］. Phytomedicine， 2019， 3（55）： 50-57.
24	GU L， SUROLIA R， LARSON-CASEY J L， et al. Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling ［J］. Cell Death Differ， 2022， 29（1）： 118-132.
25	GONG Q Y， CAI L， JING Y， et al. Urolithin A alleviates blood-brain barrier disruption and attenuates neuronal apoptosis following traumatic brain injury in mice ［J］. Neural Regen Res， 2022， 17（9）： 2007-2013.
26	DASILVA N A， NAHAR P P， MA H， et al. Pomegranate ellagitannin-gut microbial-derived metabolites， urolithins， inhibit neuroinflammation in vitro ［J］. Nutr Neurosci， 2019， 22（3）： 185-195.
27	张占琴，王辉，蒋永泼. TRPM2基因敲除通过调控GSK3β改善脂多糖诱导小鼠抑郁样行为［J］. 实用医学杂志， 2021， 37（10）： 1245-1256.
28	GIRISH C， RAJ V， ARYA J， et al. Evidence for the involvement of the monoaminergic system， but not the opioid system in the antidepressant-like activity of ellagic acid in mice ［J］. Eur J Pharmacol， 2012， 682（1/3）： 118-125.
29	YOON J H， LEE N， YOUN K， et al. Dieckol Ameliorates Abeta Production via PI3K/Akt/GSK-3beta Regulated APP Processing in SweAPP N2a Cell ［J］. Mar Drugs， 2021， 19（3）：152.
30	LONG H Z， CHENG Y， ZHOU Z W， et al. PI3K/AKT Signal Pathway： A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease ［J］. Front Pharmacol， 2021， 4（12）： 648636.
31	KEMPERMANN G. Regulation of adult hippocampal neurogen-esis-implications for novel theories of major depression ［J］. Bipolar Disord， 2002， 4（1）： 17-33.
32	李佳，林荫，吉训琦，等. 载脂蛋白E和MTHFR C677T基因多态性与精神分裂症及患者认知功能的关联性［J］. 实用医学杂志， 2021， 37（18）： 2391-2394.
33	CHEN P， CHEN F， LEI J， et al. The Gut Microbiota Metabolite Urolithin B Improves Cognitive Deficits by Inhibiting Cyt C-Mediated Apoptosis and Promoting the Survival of Neurons Through the PI3K Pathway in Aging Mice ［J］. Front Pharmacol， 2021， 11（12）： 768097.
34	KARAOSMANOGLU O. P38-beta/SAPK-inhibiting and apoptosis-inducing activities of （E）-4-chloro-2-（（3-ethoxy-2-hydroxybenzylidene） amino）phenol ［J］. Hum Exp Toxicol， 2020， 39（10）： 1374-1789.
35	LAI J， ZHANG P， JIANG J， et al. New Evidence of Gut Microbiota Involvement in the Neuropathogenesis of Bipolar Depression by TRANK1 Modulation： Joint Clinical and Animal Data ［J］. Front Immunol， 2021， 12（12）： 789647.
36	BIOQUE M， GONZALEZ-RODRIGUEZ A， GARCIA-RIZO C， et al. Targeting the microbiome-gut-brain axis for improving cognition in schizophrenia and major mood disorders： A narrative review ［J］. Prog Neuropsychopharmacol Biol Psychiatry， 2021， 3（105）： 110130.
37	SINGH R， CHANDRASHEKHARAPPA S， BODDULURI S R， et al. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway ［J］. Nat Commun， 2019， 10（1）： 89.
38	ZHANG Y， DONG Y， LU P， et al. Gut metabolite Urolithin A mitigates ionizing radiation-induced intestinal damage ［J］. J Cell Mol Med， 2021， 25（21）： 10306-10312.
39	ONISHI M， YAMANO K， SATO M， et al. Molecular mechanisms and physiological functions of mitophagy ［J］. EMBO J， 2021， 40（3）： e104705.
40	SUN N， YOULE R J， FINKEL T. The Mitochondrial Basis of Aging ［J］. Mol Cell， 2016， 61（5）： 654-666.
41	SWERDLOW R H， BURNS J M， KHAN S M. The Alzheimer's disease mitochondrial cascade hypothesis： progress and perspectives ［J］. Biochim Biophys Acta， 2014， 1842（8）： 1219-1231.
42	RYU D， MOUCHIROUD L， ANDREUX P A， et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents ［J］. Nat Med， 2016， 22（8）： 879-888.
43	CHEN P， CHEN F， LEI J， et al. Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates D-Galactose-Induced Brain Aging in Mice ［J］. Neurotherapeutics， 2019， 16（4）： 1269-1282.
44	VELAGAPUDI R， LEPIARZ I， EL-BAKOUSH A， et al. Induction of Autophagy and Activation of SIRT-1 Deacetylation Mechanisms Mediate Neuroprotection by the Pomegranate Metabolite Urolithin A in BV2 Microglia and Differentiated 3D Human Neural Progenitor Cells ［J］. Mol Nutr Food Res， 2019， 63（10）： e1801237.
45	ZHU F， JU Y， WANG W， et al. Metagenome-wide association of gut microbiome features for schizophrenia ［J］. Nat Commun， 2020， 11（1）： 1612.
46	JAUHAR S， JOHNSTONE M， MCKENNA P J. Schizophrenia ［J］. Lancet， 2022， 399（10323）： 473-486.
47	ZOU D， GANUGULA R， ARORA M， et al. Oral delivery of nanoparticle urolithin A normalizes cellular stress and improves survival in mouse model of cisplatin-induced AKI ［J］. Am J Physiol Renal Physiol， 2019， 317（5）： F1255-F1264.
48	ANDREUX P A， BLANCO-BOSE W， RYU D， et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans ［J］. Nat Metab， 2019， 1（6）： 595-603.
49	SINGH A， D'AMICO D， ANDREUX P A， et al. Urolithin A improves muscle strength， exercise performance， and biomarkers of mitochondrial health in a randomized trial in middle-aged adults ［J］. Cell Rep Med， 2022， 3（5）： 100633.

[1]	Tianyue YU,Qian GUO,Hao HU,Yujing SU,Jianhua CHEN. Advances in oxidative stress⁃related pathways with diagnostic and predictive value in schizophrenia [J]. The Journal of Practical Medicine, 2024, 40(20): 2935-2940.
[2]	Na LIU,Tiandao WANG,Chunliu YU,Yi. CHEN. Relationships of prognosis of schizophrenic patients with their serum prolactin and glial fibrillary acid protein [J]. The Journal of Practical Medicine, 2023, 39(16): 2090-2094.
[3]	ZHANG Xiaoming, GUO Bin, LIU Yanru, ZHANG Fangfang, LIU Huaqing, WANG Zhiren. . Correlation between serum FGF2，TRPC1 levels and psychiatric symptoms in patients with schizophrenia [J]. The Journal of Practical Medicine, 2023, 39(11): 1422-1426.
[4]	LU Cailian, HUANG Zhengyuan, CHEN Hon⁃ gxu, LI Shan, KANG Lin, XIONG Peng.. Research progress of long non⁃coding RNA in schizophrenia [J]. The Journal of Practical Medicine, 2021, 37(19): 2559-2562.
[5]	LI Jia, LIN Yin, JI Xunqi, KANG Yanhai, DONG Jie.. Association of APOE and MTHFR C677T gene polymorphisms with schizophrenia and cognitive function in patients [J]. The Journal of Practical Medicine, 2021, 37(18): 2391-2394.
[6]	LI Jia, LIN Yin, JI Xunqi, KANG Yanhai, DONG Jie.. Association of APOE and MTHFR C677T gene polymorphisms with schizophrenia and cognitive function in patients [J]. The Journal of Practical Medicine, 2021, 37(18): 2391-2394.
[7]	ZENG Gang, XIAO Aixiang, OUYANG Yanfang, LIANG Rongyu, WU Fengchun, LI Lili, LI Liyan. . Establishment and effect evaluation of In⁃ward comprehensive rehabilitation model on stable schizophrenia inpatients under closed management [J]. The Journal of Practical Medicine, 2021, 37(12): 1626-1630.

The neuroregulatory effects and potential applications of urolithins in mental disorders

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 49

Related Articles 7

Recommended Articles

Metrics

Comments